No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
“With two transcatheter devices approved by the U.S. Food and Drug Administration (FDA) now available, a landmark ACC Expert Consensus Decision Pathway published in 2025, and rapidly evolving evidence for transcatheter intervention, the question is no longer whether severe TR can be treated, but w...”
O’Gara et al. (Mon,) studied this question.